Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 27/11/2020
SIETES contiene 93167 citas

 
 
 1 a 20 de 35 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Mackenzie DG, Forbes JF, Rutledge P. New guidelines on hypertension. Lancet 2006;368:641. [Ref.ID 77824]
2.Tiene citas relacionadas Cita con resumen
Cruickshank JM. New guidelines on hypertension. Lancet 2006;368:641. [Ref.ID 77823]
4.Tiene citas relacionadas Cita con resumen
Anónimo. New NICE guidance rejects beta-blockers for hypertension. Scrip 2006;3171:2. [Ref.ID 77410]
5.Tiene citas relacionadas Cita con resumen
Williams B. Evolution of hypertensive disease: a revolution in guidelines. Lancet 2006;368:6-8. [Ref.ID 77336]
6.Tiene citas relacionadas Cita con resumen
Casas JP, Vallance P, Smeeth L, Hingorani AD, MacAllister R. Renoprotective effects of renin-angiotensin-system inhibitors. Authors' reply. Lancet 2006;367:900-2. [Ref.ID 76373]
7.Tiene citas relacionadas Cita con resumen
Mann JFE, Ritz E, Kunz R. Renoprotective effects of renin-angiotensin-system inhibitors. Lancet 2006;367:900. [Ref.ID 76372]
8.Tiene citas relacionadas Cita con resumen
de Zeeuw D, Lewis EJ, Remuzzi G, Brenner BM, Cooper ME. Renoprotective effects of renin-angiotensin-system inhibitors. Lancet 2006;367:899-900. [Ref.ID 76371]
9.Tiene citas relacionadas Cita con resumen
Parving H-H, Rossing P. Renoprotective effects of renin-angiotensin-system inhibitors. Lancet 2006;367:898-9. [Ref.ID 76370]
10.Tiene citas relacionadas Cita con resumen
Adler A, Stratton I, Shine B. Renoprotective effects of renin-angiotensin-system inhibitors. Lancet 2006;367:897-8. [Ref.ID 76369]
11.Tiene citas relacionadas Cita con resumen
Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, MacAllister R. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005;366:2026-33. [Ref.ID 75645]
12.Tiene citas relacionadas
Williams B, Poulter N R, Brown MJ, Davis M, McInnes GT, Potter J F, Sever PS, Thom SM, The BHS guidelines working party, for the British Hypertension Society. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004;328:634-40. [Ref.ID 73200]
13.Tiene citas relacionadas Cita con resumen
Laurent S. Guidelines from the British Hypertension Society. BMJ 2004;328:593-4. [Ref.ID 73190]
14.Tiene citas relacionadas Cita con resumen
British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. BMJ 2000;320:705-8. [Ref.ID 52054]
15. Cita con resumen
Bradbury J. Better control of systolic blood pressure called for in USA. Lancet 2000;355:1700. [Ref.ID 50955]
16.
O'Brien E, Coats A, Owens P, Petrie J, Padfield PL, Littler W A, De Swiet M, Mee F. Use and interpretation of ambulatory blood pressure monitoring; recommendations of the British Hypertension Society. BMJ 2000;320:1128-34. [Ref.ID 50602]
17. Cita con resumen
Messerli FH. Implications of discontinuation of doxazosin arm of ALLHAT. Lancet 2000;355:863-4. [Ref.ID 49882]
18.Tiene citas relacionadas
Ramsay L E, Williams B, Potter J F, Johnston GD, MacGregor GA, Poston L, Poulter N R, Russell G. Management of hypertension. Authors' reply (Ramsay et al). BMJ 2000;320:579-80. [Ref.ID 49634]
19.Tiene citas relacionadas Cita con resumen
Psaty B M, Furberg CD. Management of hypertension. Authors' reply (Psaty and Furberg). BMJ 2000;320:579. [Ref.ID 49633]
Seleccionar todas
 
 1 a 20 de 35 siguiente >>